Iovance Biotherapeutics Manufacturing LLC

Philadelphia, PA Part of Iovance Biotherapeutics Inc.

UEI
ZPQBE4ARVWL3
CAGE
9SE85
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
300 Rouse Blvd, Philadelphia, PA 19112, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Iovance Biotherapeutics Manufacturing LLC's 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Amtagvi Contract · 36C24826N0268 Veterans Integrated Service Network 8 $0
Proleukin 22ML Contract · 36C26225F0362 Veterans Integrated Service Network 22 $0

About Iovance Biotherapeutics Manufacturing LLC

Written by GovTribe AI ·

Iovance Biotherapeutics Manufacturing LLC, a subsidiary of Iovance Biotherapeutics Inc., supplies pharmaceutical and hematology-related products to the Department of Veterans Affairs as a prime contractor on the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), operating from Philadelphia, Pennsylvania with no set-aside designation and competing full-and-open across all federal awards in the source footprint.

The company's federal footprint is narrow and concentrated exclusively within the VA health system. All four prime awards in the source span three Veterans Integrated Service Network (VISN) organizations — VISN 12, VISN 22, and VISN 8 — with VISN 12 accounting for two awards valued at $250 thousand combined potential value. Recent delivery orders include a $219,575.88 firm fixed-price order from VISN 22 on April 1, 2025 for PROLEUKIN 22ML (ultimately completed July 31, 2025) and a January 5, 2026 order from VISN 8 for the same product line with ultimate completion set for April 4, 2026, subsequently terminated for convenience. Iovance holds a current GSA FSS position under the Pharmaceuticals and Drugs schedule awarded September 29, 2024, with a ceiling of $225 thousand and performance extending through September 28, 2029; an earlier interim FSS agreement with VISN 12 awarded April 17, 2024 (ceiling $25 thousand) expired October 14, 2024.

Activity is minimal — two awards in 2024, one in 2025, and one in 2026 — with a combined potential value across all four awards of $250 thousand. The vendor operates exclusively as a prime on pharmaceutical supply orders; no subcontract work appears in the source. Award volume and customer concentration reflect a specialized, low-volume supplier relationship anchored to VA pharmacy procurement through GSA's schedule mechanism rather than a broad federal customer base.

Contract vehicles

Iovance Biotherapeutics Manufacturing LLC holds a place on 1 federal contract vehicle. Active vehicles first.

Quick answers

What is Iovance Biotherapeutics Manufacturing LLC's UEI?

Iovance Biotherapeutics Manufacturing LLC's Unique Entity ID (UEI) in SAM.gov is ZPQBE4ARVWL3.

What is Iovance Biotherapeutics Manufacturing LLC's CAGE code?

Iovance Biotherapeutics Manufacturing LLC's CAGE code is 9SE85.

What is Iovance Biotherapeutics Manufacturing LLC's primary NAICS code?

Iovance Biotherapeutics Manufacturing LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Iovance Biotherapeutics Manufacturing LLC located?

Iovance Biotherapeutics Manufacturing LLC's physical address in SAM.gov is 300 Rouse Blvd, Philadelphia, PA 19112, USA.

Is Iovance Biotherapeutics Manufacturing LLC registered in SAM.gov?

Yes. Iovance Biotherapeutics Manufacturing LLC's SAM.gov registration is active through December 17, 2026.

Who is Iovance Biotherapeutics Manufacturing LLC's parent company?

Iovance Biotherapeutics Manufacturing LLC is part of Iovance Biotherapeutics Inc.

Which contract vehicles does Iovance Biotherapeutics Manufacturing LLC hold?

Iovance Biotherapeutics Manufacturing LLC holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Iovance Biotherapeutics Manufacturing LLC's most recent federal award?

Iovance Biotherapeutics Manufacturing LLC's most recent federal contract award is Amtagvi (36C24826N0268), from Veterans Integrated Service Network 8, on January 5, 2026.

On GovTribe

See Iovance Biotherapeutics Manufacturing LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login